十大藥品價格降幅達25.5%
Beginning in 2013, Taiwan’s National Health Insurance Administration established the Drug Expenditure Target as a system to adjust the price of specific pharmaceuticals “when actual drug expenditure exceeds the annual target.”
自2013年起，台灣中央健康保險署建立了「藥品費用支出目標制」（DET），以便「當實際藥品支出超過年度目標時」，調整特定藥品的價格。
establish(v.)建立=set upexpenditure(n.)(公司或國家)開支、開銷expense(n.)(個人)支出adjust(v.)調整pharmaceutical(n.)(adj.)藥品、藥物、製藥的exceed(v.)超出exceed one’s expectations超出預期
Data from the NHIA shows that in 2024, drug price adjustments under the DET were made to 4,500 drugs, leading to an expenditure reduction of NT$5.53 billion.
健保署的資料顯示，在2024年，根據DET調整藥物價格的藥物有4,500種，減少支出新台幣55.3億元。
data(n.)數據adjustment(n.)調整lead to導致;造成=bring about=cause=result in
According to the NHIA, adjustments are made to drugs the year following excessive expenditures.
根據健保署的說法，調整會在超支的年度後進行。
excessive(adj.)過度的excess(n.)過分;過量;過度an excess of~過量的
Consideration for price changes is given to “essential medicine items, price reduction, and minimum price protection to ensure a stable drug supply.”
價格變動的考慮因素為「基本藥品品項、調降幅度及基本價保障，以確保藥品穩定供應」。
essential(adj.)基本的medicine item藥物品項minimum(adj.)最小的;最低限度的maximum(adj.)最大的stable(adj.)穩定的
However, October 2023 research from IQVIA notes that updates to the DET system made on Sept. 11, 2023 could harm Taiwan’s pharmaceutical market.
然而，2023年10月IQVIA的研究指出，2023年9月11日對DET制度的更新可能會對台灣的藥品市場造成危害。
update(n.)(v.)更新
Under these changes, both the “actual transaction price” of each drug as well as “the benchmark lowest price from the Advanced 10 countries” (the U.S., Canada, Japan, Australia, the U.K., France, Germany, Belgium, Sweden and Switzerland) would be factored into price adjustments.
根據這些變更，調整藥品價格時會考慮每種藥品的「實際交易價格」，以及「十大醫藥先進國家（美國、加拿大、日本、澳大利亞、英國、法國、德國、比利時、瑞典和瑞士）的基準最低價格。
benchmark(n.)基準advanced(adj.)先進的be factored into…被納入考慮factor...into...將～納入～的考量之中
The report states that seven of the 10 leading pharmaceutical products in Taiwan would be subject to price reductions based on the benchmark lowest price of Advanced 10 countries, and because some of them have either generic or similar drugs in the NHIA system.
報告指出，台灣前十大藥品中有七種將根據十大先進國家的基準最低價格進行降價，因為其中一些在健保署系統中有學名藥或類似藥品。
state(v.)指出=notebe subject to…可能受到～影響、受制於～based on根據generic(adj.)(藥物或商品)無專利的、未註冊的generic drugs學名藥、非專利藥、仿製藥
As a result, the value of these leading 10 products could be reduced by up to 25.5% under the new DET system.
因此，在新的DET制度下，這些前十大藥品的價格可能降幅高達25.5%。
as a result因此=therefore
Certainly, saving money is a priority for the NHIA.
當然，健保署會優先考慮節省成本。
certainly(adv.)當然undoutedly(adv.)毫無疑問地=without doubt
However, the IQVIA argues that such dramatic price drops in a short period of time could cause global pharmaceutical companies to rethink how they launch new products in the Taiwan market.
然而，IQVIA認為，在短時間內如此大幅降價，可能會讓全球製藥公司重新考慮如何在台灣市場推出新產品。
drama(n.)戲劇dramatic(adj.)戲劇化的;大幅度的price drop降價=price reductionrethink(v.)重新思考think twice深思熟慮